Latest filing published 18 Jul 2019 for Telemynd, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
John Pappajohn discloses dealings in 5 companies, chiefly Emmaus Life Sciences, Inc., Vyant Bio, Inc. and Hooper Holmes Inc. In total, 57 filings cover trades dated from 25 May 2016 to 16 July 2019.
The open-market record is one-sided, with 42 purchases worth €2.6M and not one sale. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 share grants. So far in 2019, the count stands at 4 purchases and no sales.
Half of the purchases are above €18k and half below.
Most recently, on 18 July 2019, the filings show a transaction in Telemynd, Inc. The last insider purchase was made public on 23 May 2019, 2,711 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations